Medical Condition News

RSS

Mucoadhesive patch increases salivary flow rates for dry mouth sufferers: Study

A newly published study in the October 2010 issue of The Journal of the American Dental Association (JADA), conducted at New York University's College of Dentistry, concludes that use of a mucoadhesive patch, affixed to the roof of the mouth, provides statistically significant and sustainable improvements in salivary flow rates and subjective moistness for dry mouth sufferers. An estimated 30 million Americans deal with dry mouth, or xerostomia, an uncomfortable oral health condition which can have a detrimental effect on overall oral health.

6 Oct 2010

Nuevolution enters lead discovery collaboration for epigenetic disorders

Nuevolution A/S today announced that it has entered into a lead discovery collaboration focused on epigenetic disorders.A consortium between Nuevolution, EpiTherapeutics, ExpreS2ion Biotechnologies and the research group of Professor Kristian Helin (Biotech Research & Innovation Centre, University of Copenhagen) has been established with the objective of identifying and developing novel small molecule drugs against epigenetic factors.

6 Oct 2010

Michael J. Fox Foundation for Parkinson's Research announces awards totaling $10.1M

The Michael J. Fox Foundation for Parkinson's Research announced awards totaling approximately $10.1 million for five new clinical studies and 14 pre-clinical therapeutic development projects. The funding includes $2.5 million to drive four new clinical trials under the Clinical Intervention Awards, one of the Foundation's Edmond J. Safra Core Programs for PD Research.

6 Oct 2010

Nautilus Neurosciences announces exclusive co-promotion agreement for CAMBIA drug

Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company, and Mission Pharmacal Company, a privately-held pharmaceutical company focused on the women's health market announced today their exclusive co-promotion agreement for CAMBIA (diclofenac potassium for oral solution) to obstetrician's, gynecologists and other women's health medical professionals.

6 Oct 2010

Accuray announces 100,000th patient treated with CyberKnife Robotic Radiosurgery System

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that the 100,000th patient has been treated with the CyberKnife® Robotic Radiosurgery System, a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors anywhere in the body. One in four patients treated with CyberKnife radiosurgery received treatment during Accuray's fiscal 2010, which ran July 2009 to June 2010.

6 Oct 2010

NeuroDerm receives $1M grant for development of ND0611 dermal patch for Parkinson's disease

NeuroDerm, Ltd. was informed today that it was awarded a grant of $1M by The Michael J. Fox Foundation for Parkinson's Research. These funds will support the next clinical study with ND0611, a new dermal patch for the treatment of Parkinson's disease, as part of the Foundation's prestigious Clinical Intervention Awards 2010 program. This study will evaluate the safety, tolerability, levodopa pharmacokinetics, and possible clinical benefits of ND0611 in advanced Parkinson's disease patients.

6 Oct 2010

LDR expands lumbar VerteBRIDGE platform

LDR, a total spine solution company, announced today the expansion of its lumbar VerteBRIDGE product offering following 2 years of successful clinical use of the ROI-A® ALIF Cage. The new applications offer a complete range of alternatives to currently adopted lateral approaches. The new direct lateral and oblique lumbar systems have been used successfully in Europe in more than 100 cases.

6 Oct 2010

Biogen to present late-stage clinical therapies for MS at ECTRIMS Congress

Biogen Idec today announced that more than 45 company and partner-sponsored platform and poster presentations will be presented during the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Gothenburg, Sweden, October 13 - 16, 2010.

6 Oct 2010

Interim data from HyQ Phase III clinical study in primary immune deficiency presented at 26th ESID

Data from interim analyses of a Phase III clinical study in patients with primary immune deficiency (PID) who received Baxter's HyQ were presented at the 26th meeting of the European Society for Immunodeficiencies (ESID) in Istanbul, Turkey. HyQ is an immune globulin (IG) therapy facilitated subcutaneously by recombinant human hyaluronidase, a dispersion and permeation enhancer.

From Baxter International Inc. 6 Oct 2010

Orthovita's Cortoss Bone Augmentation study results to be presented at NASS Annual Meeting

Orthovita, Inc.an orthobiologics and biosurgery company, is pleased to announce that Hyun W. Bae, M.D., of The Spine Institute at Saint John's Health Center in Santa Monica, California, will present an abstract entitled, Correlation of Early Pain and Long-Term Functional Results from a Multi-Center, Prospective, Randomized, Controlled FDA-IDE Vertebroplasty Trial,at the 25th Annual Meeting of the North American Spine Society (NASS) being held October 5-9, 2010 at the Orange County Convention Center in Orlando, Florida.

6 Oct 2010

BIOTRONIK's EchoCRT clinical trial design published in European Heart Journal

BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and sponsor of clinical research to advance patient care and evidence-based medicine, announced the publication in the September 23, 2010 issue of the European Heart Journal of a peer-reviewed article that describes the rationale for the echocardiographic methods and dyssynchrony cutoff values selected for the EchoCRT study.

6 Oct 2010

MEPs organizes joint meeting to improve policies for tackling chronic diseases

In an unprecedented effort to bring prevention of chronic diseases to the top of the EU agenda, the MEP Heart Group , the MEP Group for Kidney Health , the EU Diabetes Working Group and MEPs Against Cancer organise a joint meeting today in the European Parliament, together with representatives of health professionals and health activists at European level.

6 Oct 2010

PDGF identified as key factor in proliferation and transformation of epicardial cells

In research that one day may lead to the discovery of how to regenerate tissue damaged by heart disease, investigators at Childrens Hospital Los Angeles have identified PDGF as a key factor in the proliferation and transformation of epicardial cells, one type of cell that surrounds heart muscle and contributes to vessels.

6 Oct 2010

AOA launches 'Break Through Your Pain' public education campaign

If you're living in pain, you're certainly not alone. According to a new survey released today by the American Osteopathic Association (AOA) nearly 70% of Americans report that they, or someone they care for, have experienced pain during the past 30 days. While Congress declared 2000 to 2010 the "Decade of Pain Control and Research," chronic, or reoccurring pain still affects more Americans than cancer, diabetes and heart disease combined. In fact, more than 76 million people live in pain every day.

6 Oct 2010

Lumosity.com launches Italian version of cognitive training service

Lumosity.com, the leading online provider of games that improve brain performance, announced today the launch of an Italian version of their cognitive training service -- i.lumosity.com/it. The translation of the site into Italian was sponsored by Abbott Laboratories. Abbott also sponsored hundreds of memberships to make the Lumosity.com cognitive training program available to doctors and patients throughout Italy in an effort to raise awareness about the cognitive deficits associated with HIV/AIDS.

6 Oct 2010

Fisher Wallace Laboratories launches easy-to-use medical device for depression treatment

Fisher Wallace Laboratories today announced the launch of a bold YouTube video campaign that challenges the pharmaceutical drug industry and introduces the company's easy-to-use medical device prescribed for the self-treatment of depression: the Fisher Wallace Cranial Stimulator.

6 Oct 2010

NBF's Brilliance in Bipolar Initiative receives Congressman Kennedy's endorsement

Congressman Patrick Kennedy, a long-time advocate for people living with mental illness, and Marc Kullman, co-founder of the National Bipolar Foundation, joined efforts to help reduce the stigma associated with bipolar disorder. The Brilliance in Bipolar Initiative is a national and collaborative effort to draw attention to and develop a better understanding of bipolar disorder.

6 Oct 2010

Synergy reports positive results from plecanatide Phase IIa clinical trial for chronic constipation

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced today positive results in a Phase IIa clinical trial of plecanatide (SP-304) in patients with chronic constipation. Oral plecanatide given once daily, over 14 consecutive days, at doses of 0.3, 1.0, 3.0 and 9.0 mg gave improved bowel function in patients with chronic constipation.

6 Oct 2010

ATR product improves clinical outcome in patients with soft tissue defects in foot

Reported cases, by Dr. Jan Lidström, which involve 20 patients with soft tissue defects in the foot with up to four years follow-up together with a biomechanical study, by Dr. Eric Giza, confirm the positive clinical outcome orthopedic foot surgeons have experienced with Artelon Tissue Reinforcement (ATR).

6 Oct 2010

Adeona completes enrollment in Part 2 CopperProof-2 clinical study

Adeona Pharmaceuticals, Inc., announced completion of 100% enrollment in Part 2 of its clinical study, A Prospective, Randomized, Double Blind Trial of a Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease (CopperProof-2).

6 Oct 2010

Medical Condition News

Mucoadhesive patch increases salivary flow rates for dry mouth sufferers: Study

Nuevolution enters lead discovery collaboration for epigenetic disorders

Michael J. Fox Foundation for Parkinson's Research announces awards totaling $10.1M

Nautilus Neurosciences announces exclusive co-promotion agreement for CAMBIA drug

Accuray announces 100,000th patient treated with CyberKnife Robotic Radiosurgery System

NeuroDerm receives $1M grant for development of ND0611 dermal patch for Parkinson's disease

LDR expands lumbar VerteBRIDGE platform

Biogen to present late-stage clinical therapies for MS at ECTRIMS Congress

Interim data from HyQ Phase III clinical study in primary immune deficiency presented at 26th ESID

Orthovita's Cortoss Bone Augmentation study results to be presented at NASS Annual Meeting

BIOTRONIK's EchoCRT clinical trial design published in European Heart Journal

MEPs organizes joint meeting to improve policies for tackling chronic diseases

PDGF identified as key factor in proliferation and transformation of epicardial cells

AOA launches 'Break Through Your Pain' public education campaign

Lumosity.com launches Italian version of cognitive training service

Fisher Wallace Laboratories launches easy-to-use medical device for depression treatment

NBF's Brilliance in Bipolar Initiative receives Congressman Kennedy's endorsement

Synergy reports positive results from plecanatide Phase IIa clinical trial for chronic constipation

ATR product improves clinical outcome in patients with soft tissue defects in foot

Adeona completes enrollment in Part 2 CopperProof-2 clinical study

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News